Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.
Erdes S, Nasonov E, Kunder E, Pristrom A, Soroka N, Shesternya P, Dubinina T, Smakotina S, Raskina T, Krechikova D, Povarova T, Plaksina T, Gordeev I, Mazurov V, Reshetko O, Zonova E, Eremeeva A, Chernyaeva E, Makulova T, Ivanov R. Erdes S, et al. Among authors: raskina t. Clin Exp Rheumatol. 2020 Jan-Feb;38(1):27-34. Epub 2019 Apr 16. Clin Exp Rheumatol. 2020. PMID: 31025924 Free article. Clinical Trial.
[Spondyloarthritis: modern terminology and definitions].
Erdes SF, Rebrov AP, Dubinina TV, Badokin VV, Bochkova AG, Bugrova OV, Gaydukova IZ, Godzenko AA, Dubikov AA, Ivanova ON, Korotaeva TV, Lapshina SA, Nesmeyanova OB, Nikishina IP, Otteva EN, Raskina TA, Rumyantseva OA, Sitalo AV, Smirnov AV. Erdes SF, et al. Among authors: raskina ta. Ter Arkh. 2019 May 15;91(5):84-88. doi: 10.26442/00403660.2019.05.000208. Ter Arkh. 2019. PMID: 32598681 Russian.
[The efficacy and safety of intra-articular application of a combination of sodium hyaluronate and chondroitin sulfate for osteoarthritis of the knee: a multicenter prospective study].
Alekseeva LI, Kashevarova NG, Taskina EA, Sharapova EP, Anikin SG, Strebkova EA, Raskina TA, Zonova EV, Otteva EN, Rodionova SS, Torgashin AN, Buklemishev UV, Shmidt EI, Shesternya PA, Naumov AV, Zagorodniy NV, Lila AM. Alekseeva LI, et al. Among authors: raskina ta. Ter Arkh. 2020 Jun 5;92(5):46-54. doi: 10.26442/00403660.2020.05.000631. Ter Arkh. 2020. PMID: 32598775 Russian.
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR, O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster JY, Rodriguez-Portales JA, Roux C, Zanchetta J, Zerbini CAF, Park JG, Im K, Cange A, Grip LT, Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD, Sabatine MS; LOFT Investigators. McClung MR, et al. Lancet Diabetes Endocrinol. 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. Epub 2019 Oct 31. Lancet Diabetes Endocrinol. 2019. PMID: 31676222 Clinical Trial.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension.
Burmester GR, Strand V, Rubbert-Roth A, Amital H, Raskina T, Gómez-Centeno A, Pena-Rossi C, Gervitz L, Thangavelu K, St John G, Boklage S, Genovese MC. Burmester GR, et al. Among authors: raskina t. RMD Open. 2019 Oct 18;5(2):e001017. doi: 10.1136/rmdopen-2019-001017. eCollection 2019. RMD Open. 2019. PMID: 31673415 Free PMC article. Clinical Trial.
[Analysis of the state-of-the-art of consulting medical care to patients with glucocorticoid-induced osteoporosis or its risk according to the data of a questionnaire survey (GLUCOST study)].
Baranova IA, Ershova OB, Anaev EK, Anokhina TN, Anoshenkova ОN, Batyn SZ, Belyaeva EA, Bolshakova TY, Volkorezov IA, Eliseeva LN, Kashnazarova EV, Kinyaikin MF, Kirpikova MN, Klyuchnikova EP, Korolev MA, Kuneevskaya IV, Masneva LV, Muradyants AA, Otteva EN, Petrachkova TN, Peshekhonova LK, Povzun AS, Raskina TA, Smirnova ML, Toroptsova NV, Khasanova RB, Shamsutdinova NG, Shaporova NL, Shitova NS, Shkireeva SY, Shostak NA, Lesnyak OM. Baranova IA, et al. Among authors: raskina ta. Ter Arkh. 2015;87(5):58-64. doi: 10.17116/terarkh201587558-64. Ter Arkh. 2015. PMID: 26155620 Russian.
33 results